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Enhancement of Memory-Related Long-Term
Facilitation by ApAF, a Novel Transcription Factor
that Acts Downstream from Both CREB1 and CREB2
the synthesis of new proteins (Pinsker et al., 1973; Kan-
del and Schwartz, 1982; Goelet et al., 1986; Bailey et
al., 1992; Bailey and Kandel, 1993). Both short- and long-
term sensitization are reflected in short- and long-term
facilitation of the monosynaptic connection between the
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microculture consisting of a single sensory and a singleUniversity and
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pulse of 5-HT, a transmitter released by a sensitizing tail722 West 168th Street
stimulus, produces short-term facilitation of the synap-New York, New York 10032
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Sweatt and Kandel, 1989). By contrast, five spaced ap-Italy
plications of 5-HT produce long-term facilitation that
lasts several days and is dependent on the synthesis of
new mRNA, protein, and the growth of new synaptic
contacts between the sensory and motor neurons (Mon-Summary
tarolo et al., 1986; Glanzman et al., 1990; Bailey et al.,
1992). These morphological changes in vitro are similarThe memory for sensitization of the gill withdrawal
to the synaptic growth associated with behavioral sensi-reflex in Aplysia is reflected in facilitation of the mono-
tization in vivo (Bailey and Chen, 1983, 1988).synaptic connection between the sensory and motor
Both short- and long-term facilitation involve a pre-neurons of the reflex. The switch from short- to long-
synaptic enhancement of transmitter release induced interm facilitation requires activation of CREB1, dere-
part by increases in cAMP and the consequent activa-pression of ApCREB2, and induction of ApC/EBP. In
tion of the cAMP-dependent protein kinase (PKA) (Bru-search for genes that act downstream from CREB1,
nelli et al., 1976; Schacher et al., 1988; Scholz and Byrne,we have identified a transcription activator, ApAF,
1988; Ghirardi et al., 1992). But long-term facilitationwhich is stimulated by protein kinase A and can dimer-
differs from short-term in that it requires cAMP-inducedize with both ApC/EBP and ApCREB2. ApAF is neces-
gene transcription. In Aplysia, as in mammals, the regu-sary for long-term facilitation induced by five pulses
lation of gene transcription by cAMP is mediated byof serotonin, by activation of CREB1, or by derepres-
cAMP Responsive Element (CRE) binding protein CREB.sion of ApCREB2. Overexpression of ApAF enhances
Induction of gene expression by CREB1a, the Aplysiathe long-term facilitation further. Thus, ApAF is a can-
homolog of the mammalian CREB activator, is criticaldidate memory enhancer gene downstream from both
for induction of long-term facilitation. Injection into theCREB1 and ApCREB2.
nucleus of either a CRE oligonucleotide (Dash et al.,
1990) or antibodies specific for CREB1 (Bartsch et al.,Introduction
1998) selectively blocks long-term facilitation without
affecting short-term facilitation. Conversely, injection
The formation of long-term memory in both vertebrates
into a sensory neuron of phosphorylated recombinant
and invertebrates requires the synthesis of new mRNA CREB1a protein is sufficient to induce long-term facilita-
and proteins in a critical period during and just after the tion. The facilitation lasts more than one day, requires
training (Flexner et al., 1963; Davis and Squire, 1984). transcription and translation, and occludes further facili-
In Aplysia, the switch from short- to long-term memory tation by five pulses of 5-HT (Bartsch et al., 1998). In
has been studied in the context of sensitization of the contrast, injection of antibodies against ApCREB2, a
gill withdrawal reflex, a form of acquired fear in which the CRE binding protein with homology to human CREB2
animal learns to enhance its gill and siphon withdrawal and mouse ATF4, does not inhibit long-term facilitation.
reflex in response to a noxious stimulus to the tail (Frost In fact, when paired with only a single pulse of 5-HT,
et al., 1985). Whereas one noxious stimulus to the tail which normally produces only short-term facilitation,
of Aplysia leads to short-term memory for sensitization injection of ApCREB2 antibodies leads to long-term fa-
of the reflex lasting minutes, which does not require the cilitation accompanied by a growth of new synaptic con-
synthesis of new proteins (Pinsker et al., 1970; Carew nections (Bartsch et al., 1995). In parallel, ApCREB2
et al., 1971; Kandel and Schwartz, 1982), five or more inhibits CREB1 mediated transcription. Thus, ApCREB2
spaced training trials leads to long-term memory for acts as a repressor of long-term facilitation that com-
sensitization lasting days to weeks, which does require petes functionally with the CREB1a activator. This
mechanism is not unique for Aplysia, but is evolutionarily
conserved. In Drosophila, the switch from short- to long-‡ To whom correspondence should be addressed (e-mail: erk5@
columbia.edu). term memory also is regulated by changing the activity
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Figure 1. Nucleotide Sequence of the ApAF cDNA and Amino Acid Sequences of the ApAF Protein
(A) The sequence of ApAF cDNA and the amino acid sequence of the deduced ApAF protein were derived from cDNA clones from an Aplysia
sensory neuron cDNA library. The first ATG was assigned as the translation start and the numbering of the protein sequence is on the right
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ratio between CRE binding activator dCREB2a and re- in two-hybrid screens the bZIP domain of ApCREB2
(Bartsch et al., 1995).pressor dCREB2b proteins, the fly homologs of mamma-
lian CREB and Aplysia CREB1 (Yin et al., 1994, 1995). Using the partial ApAF cDNA as a probe in Northern
blots, we found that ApAF mRNA is highly expressed inIn Aplysia, synaptic changes related to long-term
memory storage can also be regulated at the transcrip- the nervous system, and within the nervous system it
is also highly expressed in sensory neurons (Figures 4Ational level downstream from CREB1. Interfering with
expression of ApC/EBP, an immediate early gene that and 4B). We therefore cloned the full-length ApAF cDNA
by high-stringency hybridization screen of Aplysia sen-is induced by cAMP and CREB and that binds to the
CAAT box, selectively blocks the formation of long-term sory neuron specific cDNA library using the partial cDNAs
identified in two-hybrid screens as probes. The longestfacilitation (Alberini et al., 1994). To identify additional
components of the transcriptional switch downstream open reading frame identified (Figure 1A) was used for
expression of full-length ApAF protein in further experi-from CREB1, we have used as bait in a two-hybrid
screen the DNA binding and dimerization domain (bZIP) ments.
The ApAF cDNA open reading frame encodes a puta-of ApC/EBP, a gene induced by CREB. By this means,
we identified a novel protein Aplysia Activating Factor tive novel basic-leucine zipper transcription factor that
is 398 amino acids long (Figure 1A). The C-terminal do-(ApAF), and found that it interacts, through its leucine
zipper, with both ApC/EBP and ApCREB2. We find that main of the ApAF protein, which contains the bZIP, is
homologous to a number of transcription factors in-ApAF is a transcriptional activator, that it is constitutively
expressed in sensory neurons, that it can be modulated volved in differentiation. The bZIP domain of ApAF is
more than 60% homologous with the C-terminal domainsby PKA, and that it acts downstream from both CREB1
and ApCREB2. ApAF is necessary for long-term facilita- of the mammalian PAR family of transcription factors:
D-box binding protein (DBP) (Mueller et al., 1990), vitello-tion induced not only by serotonin, but also by activation
of CREB1a or by removal of ACREB2 repressor. More- genin gene binding protein (VBP) (Iyer et al., 1991), TEF
(Drolet et al., 1991), and HLF (Hunger et al., 1992). ApAFover, injection of recombinant ApAF protein not only
converts short-term facilitation, produced by one pulse also shares homology with the rodent, Xenopus, and
human E4BP4 (Cowell et al., 1992), with the C. elegansof 5-HT, into long-term facilitation lasting more than 24
hr, but even enhances long-term facilitation above the transcription factor CES-2 (Metzstein et al., 1996), and
with the Drosophila gene giant (Mechler et al., 1985)limit that can normally be reached by five pulses of 5-HT
or by the removal of the ApCREB2 repressor. Thus, (Figure 1B).
ApAF represents a novel enhancer gene for long-term
facilitation that acts downstream from both CREB1a and
ApAF Dimerizes through the Leucine Zipper with BothApCREB2.
ApC/EBP and ApCREB2 but Not with CREB1,
and Binds to the CAAT DNA Motif
The C-terminal part of ApAF contains the DNA bindingResults
and dimerization domain with hydrophobic heptade
(leucine zipper) repeats (Figure 1B). Although the recom-ApAF Is a Novel Transcription Factor that Shares
Homology with the Mammalian PAR Family binant ApAF protein forms homodimers inefficiently
through its leucine zipper in vitro (Figure 2A), it formsof Transcription Factors and with CES-2
of C. elegans stable heterodimers through its leucine zipper with both
ApCREB2 and ApC/EBP proteins in both the two-hybridIn an attempt to identify additional transcription factors
acting downstream from CREB1 that may be involved system (137 6 18 relative b-galactosidase units for Ap-
CREB21ApAF (279–398), n 5 9; 180 6 26 relative b-galac-in the transition from short-term to long-term facilitation,
we carried out a two-hybrid screen of a cDNA library tosidase units for ApC/EBP1ApAF (279–398), n 5 9
compared to ApAF (279–398) alone set as 1) and in vitrofrom the central nervous system of Aplysia using, as
bait, the DNA binding and leucine zipper domain (bZIP) binding assays (Figures 2A and 2C). On the contrary,
ApAF does not interact with CREB1a, CREB1b, or withof ApC/EBP (Alberini et al., 1994). In this screen, we
identified six cDNA clones encoding proteins that inter- CREB1c in the two-hybrid system (1.7 6 0.8 relative
b-galactosidase units for CREB1a1ApAF (279–398), n 5act strongly and specifically with the bZIP domain of
ApC/EBP. All six clones encode C-terminal parts of a 9; 0.9 6 0.7 relative b-galactosidase units for ApC/EB-
P1ApAF (279–398), n 5 9; 1.2 6 0.3 relative b-galactosi-novel Aplysia protein, Aplysia Activating Factor (ApAF)
(Figure 1A), and all six shared the predicted bZIP (Figure dase units for CREB1c1ApAF (279–398) n 5 9; com-
pared to ApAF (279–398) alone set as 1). CREB1a protein1B). In parallel, we have also cloned ApAF, using as bait
side, the nucleotide numbering on the left side. The basic and leucine zipper domain (bZIP) that interacts with ApC/EBP and ApCREB2 is
boxed with the hydrophobic heptade repeat (leucine zipper) (shaded). ApAF contains three consensus sequences for PKA phosphorylation
(double underlined) and one PKC phosphorylation site (underlined).
(B) The C-terminal bZIP of ApAF was aligned with bZIP domains of human leukemia factor (HLF), D-box binding protein (DBP), thyrotroph
embryonic factor (TEF), the chicken vitelogenin gene-binding protein (VBP) human E4BP4 transcription factor (E4BP4), the CES-2 protein of
Caenorhabditis elegans (ces2), and giant protein of Drosophila. The numbers on the left side indicate the position of the first amino acid of
the alignment in the corresponding protein. The homologous amino acids are boxed, the dots mark the hydrophobic heptade dimerization
domain.
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also does not interact with either the full-length ApAF
protein or its deletion mutants in the in vitro binding
assay (Figure 2B).
To determine the DNA binding sequence of ApAF, we
purified bacterially expressed recombinant ApAF tagged
with six N-terminal histidines. Along with ApAF protein
alone, we used a 1:1 molar mixture of ApAF:ApCREB2
and ApAF:ApC/EBP 6xHis tagged, recombinant proteins
in a PCR-based reiterative method and selected high-
affinity binding sequences from a pool of random dou-
ble-stranded oligonucleotides. Following six rounds of
selection, we cloned, sequenced, and aligned the bound
DNA oligonucleotides. The consensus binding se-
quences contained CAAT boxes (for ApAF, ATTGCAT-
CAT; for ApAF1CREB2, ATTGCACCAC; and for ApA-
F1ApCEBP, ATTGCACAAC) (Figure 2E). CAAT boxes
also are present in the core binding sites of both ApC/
EBP and ApCREB2, as well as mammalian C/EBP and
PAR family of transcription factors (Alberini et al., 1994;
Bartsch et al., 1995). Although the PCR-based reiterative
method selected high-affinity binding sequences that
are different for ApAF homo- and heterodimers, both
recombinant ApAF homo- and heterodimers bind to
DNA sequences with a core CAAT motif with similar
affinity in EMSA assays (not shown). These findings sup-
port further the structural similarity between ApAF and
the mammalian C/EBP and PAR family of transcription
factors.
ApAF Is a Transcriptional Activator Modulated
by PKA
The N-terminal part of ApAF contains a transcription
activation domain. Fusion proteins consisting of a Gal4
DNA binding domain and either full-length ApAF (1–398)
or ApAF (1–321) activate Gal4 binding UASg sites in
yeast (Figure 3A). In addition, the GAL4-ApAF (1–398)
activates UASg driven transcription in mouse F9 cells
(Figure 3B). The deduced ApAF protein sequence contains
consensus recognition/phosphorylation sequences for
Figure 2. Dimerization, Phosphorylation, and DNA Binding of ApAF the substrates of PKA and CaMKII (amino acid positions
In Vitro
67–71, 293–297, 301–305) and PKC (amino acids 208–
(A) Interaction of in vitro translated full-length ApAF (1–398),
211) (Figure 1A). Consistent with the presence of theseN-terminal deletion ApAF (279–398), ApC/EBP, and ApCREB2 (rows)
recognition/phosphorylation sequences, recombinantwith bacterially expressed glutathione S-transferase (GST) and GST
ApAF can be phosphorylated by all three kinases in vitrofusions of full-length ApAF, ApC/EBP, and ApCREB2 (columns). The
interaction between ApCREB2 and ApC/EBP was demonstrated (Figure 2D). Since PKA is a key molecular switch in the
previously (Bartsch et al., 1995). Glutathione-agarose resins satu- formation of long-term facilitation, we tested whether
rated with equal amounts of GST fusion proteins were incubated phosphorylation of ApAF by PKA will affect its transcrip-
with 35S-labeled proteins, washed, and eluted. Bound radioactively
labeled proteins were resolved by SDS-PAGE and autoradio-
graphed. ApAF forms only weak homodimers through its leucine
zipper, but interacts strongly with both ApCREB2 and ApC/EBP.
(B) Interaction of ApAF with CREB1 was measured by incubating (CaMKII), protein kinase A (PKA), protein kinase C (PKC), but not
in vitro translated, 35S-labeled, full-length CREB1 with glutathione by mitogen activated kinase (ERK1).
S-transferase (GST) and GST fusions of full-length ApAF (1–398), (E) Identification of high-affinity DNA binding sites for ApAF and
N-terminal deletion ApAF (279–398), and C-terminal deletion ApAF ApAF1ApCREB2 and ApAF1ApC/EBP heterodimers. A modified
(1–321) and full-length CREB1. Although the in vitro translated PCR-based reiterative method was used to select high-affinity bind-
CREB1 forms homodimers, ApAF does not directly interact with ing sites for ApAF and 1:1 molar mixtures of ApAF1ApCREB2 and
CREB1. ApAF1ApC/EBP. Following six rounds of selection from a pool of
(C) Interaction of in vitro translated full-length ApC/EBP and Ap- random oligomers, the bound sequences were cloned and the se-
CREB2 (rows) with glutathione S-transferase (GST) and GST fusions quences of individual clones (50 for each protein mixture) were
of full-length ApAF (1–398), N-terminal deletion ApAF (279–398), and visually aligned. The percentage of clones containing each nucleo-
C-terminal deletion ApAF (1–321). Both ApC/EBP and ApCREB2 tide at a particular position are tabulated and the consensus recogni-
interact with the C-terminal bZIP domain of ApAF [ApAF (279–398)] tion sites are indicated below. In the samples with protein mixtures,
with affinity comparable to that of full-length protein ApAF (1–398). only oligonucleotides which did not contain sequences for Ap-
(D) Phosphorylation of recombinant ApAF (1–398) in vitro. ApAF is CREB2 and ApC/EBP homodimers (Bartsch et al., 1995) were ana-
phosphorylated in vitro by calcium-calmodulin dependent kinase lyzed.
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Figure 3. ApAF Is a Transcriptional Activator
Modulated by PKA
(A) S. cerevisiae Y190 with the UASg-lacZ re-
porter plasmid were transformed by deletion
mutants of ApAF in yeast expression vector
pMA424 and grown on selection medium
overnight. The b-galactosidase activity was
standardized to protein concentration, and
the activity of the reporter in Y190 was arbi-
trarily set as 1. Both full-length ApAF protein
ApAF (1–398) and its N-terminal parts ApAF
(1–321) and ApAF (1–140) activate transcrip-
tion in S. cerevisiae.
(B) Mouse F9 cells were transiently cotrans-
fected with 1 mg of 53UASg-luc reporter plas-
mid along with 1 mg of the indicated deletion
mutants of ApAF in pRcRSV. ApAF protein
activates transcription in F9 cells.
(C) Mouse F9 cells were transiently cotrans-
fected with 1 mg of 53UASg-luc reporter plas-
mid along with the indicated amount of full-
length ApAF in pRcRSV as well as indicated
concentrations of pRcRSV-PKA (PKA) ex-
pressing the catalytic subunit of protein ki-
nase A. Activation by ApAF is enhanced upon
cotransfection with PKA.
(D) Mouse F9 cells were transiently cotrans-
fected with 1 mg of a luciferase enhancer-
reporter plasmid containing the consensus
ApAF DNA binding site (Figure 2D) along with
1 mg of pRcRSV-ApAF (ApAF) and 1 mg
pRcRSV-PKA (PKA). Although the basal expression of the ApAF consensus binding site driven luciferase reporter in F9 cells is enhanced by
cotransfection with PKA, this activation is further potentiated by cotransfecting ApAF. Thus, ApAF driven transcription is activated by PKA,
either directly or indirectly.
All transfections in F9 cells were adjusted to 4 mg total DNA with pRcRSV vector DNA. In the experiments reported in (B), (C), and (D), the
firefly luciferase activity of the reporters was normalized to Renilla luciferase activity from 0.2 mg of the cotransfected pRL-RSV expression
plasmid. The relative luciferase activity was calculated by comparing the activities measured in cotransfection experiments to the activity of
luciferase reporters alone (arbitrarily set at 1.0). Each bar represents the mean of at least nine independent transfections 6 SEM.
tional activity. We found that the expression of a UASg- of the protein, Ab2 was directed against ApAF (142–398).
Both antibodies, but not the preimmune sera, recognizeluciferase reporter is enhanced in F9 cells when the Gal4
DNA binding domain-ApAF fusion protein is cotrans- a 40 kDa protein in immunoprecipitations from 35S-labeled
extracts from Aplysia sensory neurons. The specific in-fected with the catalytic subunit of PKA (Figure 3C).
In addition, a reporter driven by the high-affinity ApAF teractions with ApAF could be blocked by preincubating
the immune sera with recombinant ApAF (Figure 4B).binding sequence that we had determined by optimal
site selection (Figure 2E) shows increased activity when Both anti-ApAF antibodies also recognize a 40 kDa
ApAF protein in Western blots. Consistent with the con-ApAF is cotransfected, and this activity is enhanced
further when the catalytic subunit of PKA is coexpressed centration of ApAF mRNA, the concentration of ApAF
protein in neurons does not change following extended(Figure 3D). Thus, ApAF mediated transcription can be
regulated by PKA, either directly or indirectly. exposure of intact animals to 5-HT in vivo (Figure 4D).
ApAF Is an Activator Necessary for Long-TermApAF Is Constitutively Expressed in Aplysia
Sensory Neurons Facilitation Induced by Spaced
Training by 5-HTApAF is highly and constitutively expressed in the ner-
vous system and the gill. Interestingly, this tissue distri- We next examined the role of ApAF in both short- and
long-term facilitation in the monosynaptic connectionsbution parallels the mRNA expression of ApCREB2 and
ApC/EBP (Figure 4A). However, in contrast to ApC/EBP, between the sensory and motor neurons by perturbing
the ApAF expression with antibodies. Injection into thewhich is present in neurons at low levels in the basal
state and is induced by prolonged exposure to 5-HT, sensory neuron of either preimmune or immune (Ab1
and Ab2) antisera did not affect either the basal synapticthe expression of ApAF mRNA is constitutive and high
and is not affected by extended exposure to 5-HT in transmission (data not shown) or the short-term facilita-
tion induced by one pulse of 5-HT (Figures 5A and 5B).vivo (Figure 4C).
Within the nervous system, ApAF mRNA is highly ex- Long-term facilitation induced by five pulses of 5-HT
was selectively inhibited by injection of the immune Ab1pressed in sensory neurons. To characterize the expres-
sion of ApAF protein in those neurons, we raised two and Ab2 anti-ApAF antisera. By contrast, the long-term
facilitation was not blocked by the correspondingrabbit polyclonal antibodies: Ab1 was raised against
ApAF (1–140), the first 140 amino acid N-terminal domain preAb1 and preAb2 preimmune sera or by Ab1 and Ab2
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Figure 4. ApAF Is Constitutively Expressed
in Aplysia Neurons
(A) Expression of ApAF in Aplysia tissues.
Northern blot analysis of ApAF mRNA expres-
sion compared to that of ApCREB2, ApC/
EBP, and actin. The tissue used as the source
of RNA is indicated above each lane. 5 mg of
total RNA was loaded in each lane. The
mRNAs were detected by hybridization with
a full-length cDNA probe of ApAF (top panel),
ApCREB2 (second panel), and ApC/EBP
(third panel) and a partial cDNA probe of
Aplysia actin (bottom). ApAF mRNA is highly
expressed in central nervous system and gill.
This expression parallels that of ApCREB2
and ApC/EBP. To visualize the very low basal
expression of ApC/EBP, the Northern blot hy-
bridized with ApC/EBP probe was exposed
for 53 longer than blots probed with ApAF,
ApCREB2, and actin probes.
(B) ApAF protein expression in Aplysia sen-
sory neurons. Aplysia sensory clusters were
dissected from anesthetized animals and
metabolically labeled with 35S-methionine.
The neurons were homogenized in RIPA
buffer and ApAF protein was immunoprecipi-
tated using anti-ApAF antibodies (Ab1 and
Ab2), preimmune sera (pre Ab1 and pre Ab2),
and immune serum preadsorbed with gluta-
thione-agarose resin saturated with recombi-
nant GST-ApAF protein (Ab1 block and Ab2
block). Positions of molecular mass markers
in kDa are indicated. The specific ApAF sig-
nals are indicated by arrowheads. ApAF is
expressed in the Aplysia central nervous sys-
tem and migrates on SDS-PAGE with an ap-
parent molecular weight of around 40 kDa.
Under the cell lysis conditions employed, the recombinant ApAF protein does not show significant dimerization with recombinant ApC/EBP
or ApCREB2 proteins in vitro (not shown).
(C) Northern blot analysis of total RNA isolated from nervous system of Aplysia exposed to 5-HT in vivo. The nervous system of Aplysia
exposed to 50 mM 5-HT in vivo for the time indicated. 5 mg of total CNS RNA was separated in 1% agarose gels, blotted, and hybridized with
32P- labeled cDNA probes indicated on the left side. ApAF mRNA expression is not affected by extended exposure of Aplysia to 5-HT in vivo.
The findings that ApC/EBP mRNA is induced and that ApCREB2 mRNA concentration remains constant following 5-HT exposure have been
previously published (Alberini et al., 1994; Bartsch et al., 1995) and are included for comparison.
(D) Western blot analysis of CNS protein extracts prepared from Aplysia exposed to 5-HT in vivo as in (C) for the times indicated. The blot
was probed with anti-ApAF antibodies Ab1. The concentration of ApAF mRNA and protein in Aplysia neurons does not change upon 5-HT
exposure.
The extended exposure to 5-HT in vivo represents massed training as compared to spaced training used in Aplysia cell cultures in vitro.
Applying this massed training in vitro induces long-term facilitation, albeit less efficiently.
sera blocked by recombinant ApAF (Figures 5C and 5D; induced by 5-HT and cAMP), but not with CREB1a (Fig-
ure 2B). In contrast to CREB1a, injection of ApAF is not5.71% 6 7.05%, n 5 17 for Ab1 and 6.33% 6 13.12%,
n 5 6 for Ab2 compared to 91.6% 6 21.31%, n 5 10 sufficient to induce long-term facilitation at 24 hr, even
when ApAF has been phosphorylated by PKA (3.59% 6for preimmune preAb1, 79.6% 6 25.3%, n 5 5 for ApAF
blocked blockAb1, 104.64% 6 26.23%, n 5 11 for ApAF 2.32%, n 5 5 for ApAF, 2.84% 6 3.14%, n 5 7 for
PKA phosphorylated ApAF compared to 43.93% 6blocked blockAb2, and 79.6% 6 12.95%, n 5 15 for
53 5-HT exposure). These results indicate that ApAF is 12.53%, n 5 8 for phospho-CREB1a injection). We there-
fore asked, is ApAF necessary for some downstreamnecessary for long-term facilitation in Aplysia sensory
neurons. steps of the long-term facilitation induced by CREB1a?
To address this question, we tested whether the long-
term facilitation induced by phosphorylated CREB1aApAF Is Necessary for the Long-Term
Facilitation Induced by Injection alone, without 5-HT exposure, can be blocked by in-
terfering with the function of ApAF using both specificof Phosphorylated CREB1a
As is the case with CREB1 and ApCREB2 (Bartsch et al., anti-ApAF antibodies and a dominant negative inhibitor,
truncated ApAF (279–398). We first injected into the sen-1995, 1998), ApAF is constitutively expressed in sensory
neurons. Our in vitro binding studies indicate that ApAF sory neurons phosphorylated CREB1a protein, together
with either Ab1 antiserum or preimmune preAb1 antise-can form stable dimers with both ApCREB2 and with the
product of the immediate early gene ApC/EBP (which is rum. When CREB1a was injected together with the Ab1
Enhancement of Long-Term Facilitation by ApAF
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Figure 5. ApAF Is Necessary for Long-Term Facilitation
Injection of anti-ApAF antibodies into sensory neurons does not affect short-term facilitation but blocks long-term facilitation in sensory-
motor synapses. Bar graphs represent the effect of injection of anti-ApAF antisera (Ab1 and Ab2) on short-term (A and B) or long-term
facilitation (C and D). Both preimmune sera affected neither short- nor long-term facilitation, only one preimmune serum (Ab1 pre) is shown.
Both Ab1 and Ab2 antibodies selectively block long-term facilitation without affecting short-term facilitation. This block can be abolished by
preincubating the immune serum with recombinant ApAF (Ab1 block and Ab2 block).
The height of each bar corresponds to the mean percentage change 6 SEM in EPSP amplitude tested 10 min after one pulse of 5-HT (A and
B) or 24 hr after five pulses of 5-HT (C and D). ** p , 0.01 compared with noninjected neurons exposed to five pulses of 5-HT. (B and D)
Examples of EPSPs recorded at indicated time points in neurons injected with anti-ApAF antisera. Calibration bars are 10 mV; 25 ms.
antiserum, the resulting long-term facilitation was signif- We then injected phosphorylated-CREB1a protein 1:1
diluted in injection buffer or 1:1 molar mix with the domi-icantly reduced compared to CREB1a injection alone
(0.26% 6 7.72%, n 5 19, p , 0.01 compared to 43.93% 6 nant negative inhibitor ApAF (278–398), and it again
blocked the long-term facilitation induced by CREB1a12.53%, n 5 8 for phospho-CREB1a injection). This effect
is specific to CREB1, since coinjection of the preimmune as much as it blocked the facilitation induced by 5-HT
(22.21% 6 8.7%, n 5 16 for pCREB1a 1 buffer com-antiserum had little effect on phospho-CREB1a induced
long-term facilitation (41.52% 6 13.70%, n 5 11). pared to 220.43% 6 9.48%, n 5 9 for pCREB1a 1 ApAF
(279–398) and 215.54% 6 9.48%, n 5 16 for bufferWe next found that the injection of a dominant nega-
tive inhibitor, truncated ApAF (279–398) which contains alone). Since ApAF (279–398) does not interact with
CREB1a directly (Figure 2B), we conclude that interfer-only the b-ZIP domain, also inhibits long-term facilitation
induced by five pulses of 5-HT (20.02% 6 8.74%, n 5 ing with ApAF does not directly inhibit CREB1a action.
Rather, ApAF seems to act in parallel or downstream7 for ApAF (279–398) 1 53 5-HT compared to 67.75% 6
18.24%, n 5 7 for 53 5-HT alone, Figures 6E and 6F). from CREB1a. Since either injection of the full-length
Cell
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Figure 6. ApAF Injection Converts Short-Term Facilitation Induced by One Pulse of 5-HT to Long-Term Facilitation, and Enhances Long-Term
Facilitation Induced by Removal of ApCREB2 Repressor or Five Pulses of 5-HT
Bar graphs represent the effects of the injection of recombinant full-length ApAF protein (ApAF) or truncated C-terminal ApAF (279–398)
Enhancement of Long-Term Facilitation by ApAF
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ApAF, PKA phosphorylated ApAF, or the ApAF (279–398) facilitation induced by five pulses of 5-HT (89.10% 6
40.14%, n 5 6 for 13 5-HT paired with coinjection ofby themselves did not induce long-term facilitation, we
therefore favor the idea that, in the induction of long- ApAF protein and anti-ApCREB2 antibodies compared
to 54.24% 6 24.79%, n 5 8 for 13 5-HT with injectionterm facilitation, ApAF acts functionally downstream
from CREB1a. of anti-ApCREB2 antibodies alone, Figures 6E and 6F).
Thus, in addition to acting downstream from CREB1,
ApAF also can act as an enhancer of long-term facilita-ApAF Enhances Long-Term Facilitation Induced
by the Removal of ApCREB2 tion, downstream from ApCREB2, by amplifying the fa-
cilitation induced by a single pulse of 5-HT upon removalHow does ApAF functionally relate to ApCREB2? We
have previously found that short-term facilitation in- of ApCREB2.
duced by one pulse of 5-HT is converted into long-term
facilitation by pairing the one pulse of 5-HT with injection Injection of ApAF Protein Lowers the Threshold
for Long-Term Facilitation and Enhancesinto sensory neurons of anti-ApCREB2 antibody. The
long-term facilitation induced by removal of ApCREB2 Its Amplitude
The amplitude of long-term facilitation induced by coin-phenocopies the long-term facilitation induced by five
pulses of 5-HT; it is blocked by the inhibitors of RNA jecting anti-ApCREB2 antibody with recombinant ApAF
protein paired with one pulse of 5-HT was larger thanand protein synthesis and is accompanied by growth of
new synaptic connections (Bartsch et al., 1995). Since the facilitation induced by injection of anti-ApCREB2
alone paired with 5-HT pulse. We have previously shownApAF can dimerize with ApCREB2, we first asked
whether ApAF is necessary for long-term facilitation in- that long-term facilitation induced by removal of the
ApCREB2 repressor paired with one pulse of 5-HT phe-duced by the removal of the ApCREB2 repressor. Injec-
tion of ApCREB2 antibody paired with a single pulse nocopies the long-term facilitation induced by five
pulses of 5-HT (Bartsch et al., 1995). We therefore askedof 5-HT induces long-term facilitation comparable to
facilitation induced by five pulses of 5-HT. We have now whether one can modify the threshold of transition from
short- to long-term facilitation or amplitude of long-termfound that the long-term facilitation induced by removal
of ApCREB2 paired with one pulse of serotonin can be facilitation induced by five pulses of 5-HT by manipulat-
ing the concentration of ApAF in sensory neurons.completely blocked by coinjection of anti-ApAF antibod-
ies (2.39% 6 10.33%, n 5 4 for 13 5-HT paired with Toward that end, we first injected into sensory neu-
rons purified recombinant ApAF (1–398) protein as wellcoinjection of both anti-ApAF and anti-ApCREB2 anti-
bodies compared to 54.24% 6 24.79%, n 5 8 for 13 as a truncated ApAF (279–398) containing the C-terminal
bZIP domain of ApAF. Both recombinant ApAF proteins5-HT with injection of anti-ApCREB2 antibodies alone,
Figures 6E and 6F). This indicates that although ApAF interact with ApC/EBP and CREB2 with similar affinities
in vitro (Figure 2C). When paired with a single pulse ofis constitutively expressed in the basal state and can
dimerize with ApCREB2 in vitro, the necessary role of 5-HT, injection of ApAF (1–398) or ApAF (279–398) did
not affect the amplitude of short-term facilitation mea-ApAF for long-term facilitation in vivo is downstream
from ApCREB2. sured at 10 min after 5-HT exposure (Figures 6A and
6B). However, when one pulse of 5-HT was paired withWe next asked, does injection of ApAF protein also
enhance the long-term facilitation induced by pairing injection of full-length ApAF (1–398), it produced long-
term facilitation that persisted more than 24 hr. By con-a single pulse of 5-HT with removal of the ApCREB2
repressor? We have found that coinjection of recombi- trast, injection of the truncated ApAF (279–398) or injec-
tion of buffer did not produce long-term facilitation whennant full-length ApAF with anti-ApCREB2 antibody sig-
nificantly increased both the long-term facilitation in- paired with a single pulse of 5-HT (Figures 6C and 6D).
Since both ApAF (1–398) and ApAF (279–398) proteinsduced by injection of anti-ApCREB2 antibody alone
paired with a single pulse of 5-HT and the long-term do not differ in their affinities for dimerization with Ap-
protein into sensory neurons. Following injections of ApAF proteins, neuronal cultures were exposed to long-term training (53 5-HT), short-
term training (13 5-HT), or not exposed to 5-HT.
(A and B) Injection of ApAF or the truncated ApAF (279–398) does not induce short-term facilitation alone or affect short-term facilitation
induced by one pulse of 5-HT. The height of each bar corresponds to the mean percentage change 6 SEM in EPSP amplitude tested 1 hr
after ApAF protein injection and 10 min after one pulse of 5-HT.
(C and D) Injection of ApAF converts short-term facilitation normally induced by one pulse of 5-HT into long-term facilitation. The truncated
ApAF (279–398) protein which lacks the activation domain, but still interacts in vitro with ApCREB2 and ApC/EBP with affinity comparable to
full-length ApAF, does not convert the one pulse 5-HT short-term training into long-term facilitation. The height of each bar corresponds
to the mean percentage change 6 SEM in EPSP amplitude tested 24 hr after protein injection and one pulse of 5-HT (*p , 0.05 compared to
cells exposed to one pulse of 5-HT only). Injection of neither ApAF nor the truncated ApAF bZIP induces long-term facilitation without 5-HT
exposure.
(E and F) Injection of ApAF enhances the long-term facilitation induced by either the injection of anti-ApCREB2 antibody paired to one pulse
of 5-HT or long-term facilitation induced by five pulses of 5-HT. The height of each bar corresponds to the mean percentage change 6 SEM
in EPSP amplitude tested 24 hr after ApAF protein injection and five pulses of 5-HT (* p , 0.05 compared to cells exposed to five pulses of
5-HT only). Unlike injection of full-length ApAF protein, injection of ApAF (279–398) inhibits the long-term facilitation induced by five pulses
of 5-HT. Since the full-length ApAF and ApAF (279–398) interact with both ApCREB2 and ApC/EBP with similar affinity (Figure 2C), the simple
titration of ApCREB2 or ApC/EBP seems unlikely to be responsible for the enhancement of facilitation by ApAF.
(B, D, and F) Examples of EPSPs recorded at indicated time points in neurons injected with recombinant ApAF proteins. Calibration bars are
10 mV; 25 ms.
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CREB2 or ApC/EBP in vitro, the induction of long-term body, which facilitates the long-term facilitation by low-
ering the threshold of long-term facilitation to a singlefacilitation by full-length ApAF protein does not seem
to be achieved by simply titrating out these proteins. pulse of 5-HT, does so via ApAF. This long-term facilita-
tion is blocked by coinjection of anti-ApAF antibody.Rather, the data suggest that ApAF can serve as an
activator to enhance the transition from short-term to The idea that ApAF is downstream from ApCREB2 is
further supported by the converse finding that long-termlong-term facilitation, perhaps by dimerizing with ApC/
EBP. Consistent with this idea, pairing of the injection facilitation, achieved by one pulse of 5-HT following
removal of ApCREB2 with anti-ApCREB2 antibody, alsoof ApAF protein with five pulses of 5-HT significantly
increased the amplitude of long-term facilitation com- is enhanced following the coinjection of ApAF protein.
The protein partner most likely to interact with ApAFpared to the long-term facilitation induced by five pulses
of 5-HT alone (81.38% 6 22.70%, n 5 7 for ApAF injec- is the other downstream activator, ApC/EBP. Our data
suggest that ApAF is recruited to act as an enhancertion paired with 53 5-HT; compared to 56.76% 6
12.96%, n 5 11 for 53 5-HT alone, Figures 6E and 6F). of long-term synaptic plasticity only after CREB1a is
phosphorylated and the activity ratio between CREB1By contrast, as we have seen, injection of the truncated
ApAF (279–398), containing the bZIP domain only, signif- and ApCREB2 is changed. The finding that ApAF only
becomes critical for facilitating gene expression aftericantly reduces the long-term facilitation after five pul-
ses of 5-HT as compared to buffer injected controls the CREB1/ApCREB2 initiation complex is activated is
further supported by the finding that the facilitation in-(20.00% 6 8.74%, n 5 7 for injection of ApAF (279–398)
paired with 53 5-HT compared to 81.38% 6 22.70%, duced either by activation of CREB1a or by derepression
of ApCREB2 can be blocked by both anti-ApAF antibod-n 5 7 for 53 5-HT and 26.76% 6 4.02%, n 5 13 for
buffer injected controls, Figures 6E and 6F). ies or by a dominant negative inhibitor of ApAF. Once
ApC/EBP and the downstream cascade of gene activa-These data indicate that ApAF is capable of enhancing
synaptic plasticity. First, increasing the intracellular con- tion is induced, ApC/EBP can act in one of two ways.
One, it can act as a homodimer to activate downstreamcentration of ApAF can convert short-term facilitation
(produced by one pulse of 5-HT) to long-term facilitation. genes. In addition ApC/EBP can recruit ApAF and Ap-
CREB2 to form two new heterodimers, ApAF-ApC/EBPSecond, increasing the intracellular concentration of
ApAF can enhance the long-term synaptic facilitation and ApCREB2-ApC/EBP. The specific roles of the indi-
vidual complexes between ApAF, ApCREB2, and ApC/above the limit that can be reached by training with
5-HT alone. Furthermore, it also increases the long-term EBP in the formation and maintenance of long-term facil-
itation is not yet known. Since each dimer binds a differ-facilitation induced by pairing of one pulse of 5-HT with
removal of ApCREB2 repressor. ent DNA motif, it is likely that this dimerization may target
different DNA sequences and serve to broaden the num-
ber of targets that can be activated by the resultingDiscussion
complexes.
The model illustrated in Figure 7 is based on molecularApAF Is a Novel Transcriptional Activator that Acts
studies of sensitization in Aplysia and illustrates thatDownstream from CREB1 and CREB2
even for a simple form of learning, the switch from short-ApAF represents a novel transcription factor important
to long-term is complex and involves a number of inter-for long-term facilitation in Aplysia. The experiments
related transcriptional activators and repressors. Be-carried out with ApAF, both alone and in combination
cause sensitization is a simple form of learning, we thinkwith other factors, suggest a model for the transition
that the several components we have encountered infrom short- to long-term facilitation in Aplysia sensory
Aplysia are likely to represent only the core conservedneurons. According to this model (Figure 7), the switch
components of the switch. It is probable that with other,becomes activated when the transcription factor CREB1
more complex learning processes, additional compo-becomes phosphorylated and the activity ratio between
nents will also be recruited.CREB1 and ApCREB2 is changed. Once activated,
CREB1 regulates a cascade of downstream genes that
are necessary for the induction of the long-term process. ApAF Can Serve as a Memory Enhancer Gene
in Modulating the Strength of Long-TermIn addition to CREB1, two other downstream activators
are involved in this switch: ApC/EBP and ApAF. Unlike Synaptic Plasticity and Memory Storage
In contrast to CREB1, phosphorylated ApAF alone isApC/EBP, which is present only at very low levels in the
basal state and is induced by 5-HT, ApAF is constitu- unable to induce long-term facilitation. However, ApAF
is a powerful modulator of long-term facilitation. This istively expressed in the sensory neurons in the basal
state, and its level of expression is not affected by the evident in several ways. First, when paired with one
pulse of 5-HT (which activates PKA and results inexposure of the sensory neurons to 5-HT. In addition
to these three known activators, there are two known CREB1a phosphorylation), overexpression of ApAF con-
verts short-term facilitation into long-term facilitation.repressors: CREB1b and ApCREB2.
Where in this cascade does ApAF act to enhance Second, when paired with removal of ApCREB2, ApAF
extends the long-term facilitation beyond limit set byfacilitation? ApAF forms poor homodimers but hetero-
dimerizes well with both ApCREB2 and ApC/EBP. Al- five pulses of 5-HT. Third, ApAF also extends the long-
term facilitation produced by five pulses of 5-HT.though ApAF could dimerize with ApCREB2 in the basal
state, our evidence indicates that the function of ApAF Earlier work in Drosophila and Aplysia first indicated
that long-term memory storage, and the synaptic plas-necessary for long-term facilitation is downstream from
ApCREB2. We find that injection of anti-ApCREB2 anti- ticity that underlies it, can be both increased and de-
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Figure 7. Model: Regulation of the Transition from Short- to Long-Term Facilitation Involves the Cascade with Cooperative Action of CREB1,
CREB2, ApC/EBP, and ApAF
ApAF is constitutively expressed in sensory neurons and its level of expression is not affected by exposure of neurons to 5-HT. Although
ApAF can form heterodimers with both ApCREB2 and ApC/EBP in vitro, we propose that the major functional role of ApAF for long-term
facilitation is downstream from both CREB1 and ApCREB2.
Upon induction of ApC/EBP in sensory neurons by 5-HT, the ApC/EBP protein can interact with ApAF. Since each dimer (ApCREB2-ApC/
EBP, ApC/EBP-ApC/EBP, ApAF-ApC/EBP) can bind different DNA motifs (BS1, BS2, and BS3, respectively), the dimerization may serve to
broaden the number of genes that can be activated. Based on our results, we presume that the major role of ApAF is in the stabilization of
long-term facilitation rather than in its initiation. In contrast to CREB1a, ApAF alone, even when phosphorylated by PKA, is unable to induce
long-term facilitation. In the basal state, the threshold for induction of long-term facilitation is maintained by the functional balance of the
products of the CREB1 gene (CREB1a, CREB1b, and CREB1c) and the ApCREB2 repressor. Only when paired with one pulse of 5-HT, which
activates PKA and induces CREB1a phosphorylation, does ApAF overexpression convert short-term into long-term facilitation. Once CREB1a
is activated and the repression by ApCREB2 is removed, the expression of genes downstream from CREB1, including expression of ApC/
EBP, is induced. We propose that ApAF is critical for enhancing and stabilizing gene expression changes induced by phosphorylated CREB1a
and derepression of ApCREB2.
creased by modulating the activity at the level of CREB. stream from PKA and CREB. First, pharmacologically
inhibiting type IV phosphodiesterases by rolipram in-These earlier studies indicated that long-term memory
in the intact animal and long-term synaptic facilitation creased cAMP response to forskolin in hippocampal
slices and improved long-term memory retention in con-in the neural circuit storing a memory can either be
depressed or enhanced by altering the ratio of CREB text conditioning (Barad et al., 1998). Second, enhance-
ment of memory has now also been shown in transgenicactivators to CREB repressors (Dash et al., 1990; Yin et
al., 1994, 1995; Bartsch et al., 1995, 1998). There is now mice overexpressing in the forebrain NR2B, an NMDA
receptor subunit with a long open time. These mice showevidence that positive and negative regulators of CRE
and CREB are also part of the switch from short- to both enhanced LTP in the hippocampus and improved
memory formation (Tang et al., 1999).long-term memory in mice (Bourtchuladze et al., 1994;
Gass et al., 1998; Impey et al., 1998). In addition, there We here provide evidence for the enhancement of
long-term synaptic plasticity at a functional step down-is now good pharmacological and genetic evidence in
mice that synaptic plasticity and long-term memory can stream from both CREB1a and ApCREB2. Similarly,
ApAF and its potential mammalian homologs could alsobe enhanced by modulating the signaling pathways up-
Cell
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Purification of Recombinant Proteinsserve as modulators to enhance memory storage. Thus,
The induction and purification of GST fusion proteins were done asanalysis of the signaling cascades activated by learning
described (Frangioni and Neel, 1993). His6-ApAF fusion proteinsprocesses reveals multiple sites of modulation. In addi-
were expressed and purified using the QIAexpress system (Qiagen,
tion to inhibitory constraints, (memory repressor genes; denaturing protocol). The bound His6-ApAF proteins were renatured
Abel et al., 1998), there seem also to be positive regula- on Ni-NTA resin, eluted with 250 mM imidazole, and dialyzed.
tors of long-term synaptic strength that may serve as
Immunoprecipitationmemory enhancer genes.
The sensory clusters removed from anesthetized Aplysia were la-
beled with 35S-methionine overnight at 188C, homogenized in 10 mM
Experimental Procedures Tris pH 7.2, 350 mM NaCl, 0.5% Triton X-100, 50 mM b-glycerophos-
phate, 25 mM NaF, 1 mM NaVO4, 2 mM DTT, 1 mM PMSF, 5 mM
General Methods benzamidine, and 10 mg/ml each of chymostatin, leupeptin, antipain,
Standard manipulations of E. coli, S. cerevisiae, proteins, and nu- and pepstatin A. After diluting 1:1 with 23 RIPA , the extract was
cleic acids were performed essentially as described in Bartsch et precleared with Protein A-Sepharose (Pharmacia) for 1 hr at 48C,
al. (1995) and Ausubel et al. (1993). and incubated with ApAF-Ab1 or ApAF-Ab2 antibodies for 1 hr at 48C
followed by Protein A-Sepharose. The immunoprecipitated proteins
were resolved by 10% SDS-PAGE, and visualized by fluorography
Plasmids and Cloning (Amplify, Amersham).
Cloning was generally done by PCR using pfu DNA polymerase
(Stratagene). The two-hybrid Aplysia CNS specific cDNA library was DNA Binding Site Selection
constructed as described previously (Bartsch et al., 1995). Optimal recognition sequences for DNA binding of ApAF and its
For E. coli expression, the initiation codon of ApAF was replaced dimers with ApCREB2 and ApC/EBP were determined by a PCR
by an NcoI restriction site by PCR and cloned in the NcoI-SacI site assisted binding site selection method (Norby et al., 1992; Bartsch
of pGEX-KG (Guan and Dixon, 1991) and pET-30 (Novagen, modified et al., 1995). The oligonucleotides that bound in 150 mM KCl were
by replacing the NdeI-NcoI fragment by a synthetic oligonucleotide eluted by 1 M KCl, diluted, and PCR amplified. After six cycles of
encoding the initiating methionine followed by six histidines). ApAF binding and PCR amplification, the amplified products were cloned
(1–398) refers to the full-length protein, ApAF (1–321) and ApAF in Bluescript (Stratagene) and sequenced. The consensus se-
(1–140) are C-terminal deletion mutants lacking the bZIP domain, quences for ApAF homodimer, and ApAF1ApC/EBP and ApAF1Ap-
ApAF (142–398) and ApAF (279–398) are N-terminal deletion mu- CREB2 heterodimers were derived from 50 independent clones for
tants. The ATG codon with the NcoI site was inserted preceding each binding assay mix. For heterodimers, only clones not con-
the S279 in ApAF (279–398). The mammalian expression construct taining the binding sequences for homodimeric ApCREB2, ApC/
pRcRSV-ApAF was made by subcloning the corresponding cDNAs EBP, or ApAF were analyzed.
in pRcRSV (Invitrogen). The reporter pGL3-ApAF was made by clon-
ing a single high-affinity ApAF binding site (determined by reiterative In Vitro Protein Binding Assay
binding described below) into a pGL3 promoter luciferase reporter 35S-methionine-labeled ApCREB2 and ApC/EBP were translated in
plasmid (Promega). The plasmids pRcRSV-PKA C-a1 expressing the TNT rabbit reticulocyte lysate (Promega). 10 ml of the lysates
the PKA catalytic subunit were generously provided by R. Goodman. containing in vitro translated proteins was diluted and mixed with
25 ml of Glutathione-Sepharose beads, saturated with Glutathione
S-transferase (GST) or GST-ApAF fusion proteins in 400 ml of PBS,Aplysia Sensory Cluster cDNA Library Construction
and mixed for 1 hr at room temperature. The bound complexes wereand Full-Length ApAF cDNA Cloning
washed with 20 ml of 0.1% Triton X-100 in PBS on a minicolumnTwenty Aplysia sensory clusters were homogenized in 4 M guanid-
(Wizard, Promega), eluted in SDS sample buffer, and resolved byium thiocyanate/Tris-HCl pH 7.5, centrifuged at 5000 g for 15 min,
10% SDS-PAGE.and the polyA1 mRNA was purified directly from the 43 diluted
supernatant on oligo dT cellulose (Pharmacia). The cDNA library
F9 Cell Culture, Transfections, and Reporter Gene Assayswas constructed in lZAP using random hexamers according to
Undifferentiated mouse F9 cells were transfected using Lipofect-manufacturers’ instructions (Stratagene). The average insert size is
amine (BRL). b-galactosidase and luciferase activities were quanti-2 kb. The full-length ApAF clones were cloned by colony hybridiza-
tated by chemiluminescence (Galacton Plus, Tropix, and a Lucifer-tion at high stringency using the partial ApAF cDNAs isolated in
ase assay kit, Promega) in a Turner 20e luminometer.two-hybrid screen as probes. Twelve clones were sequenced, five
of which contained identical longest 59 extension.
Aplysia Cell Culture and Electrophysiology
Aplysia sensory neurons from the pleural ganglia of adult animals
(80–100 g) were cocultured with the motor neuron L7 from juvenileAplysia CNS Two-Hybrid cDNA Library Construction, Cloning
animals (0.5–4 g). After 4–5 days in culture, the strength of synapticof Interacting Proteins in Yeast and GAL4 DNA Binding
connections between the sensory and motor cells was measuredDomain Activation Assay
electrophysiologically, as previously described (Montarolo et al.,The Aplysia CNS cDNA library was synthesized in pGAD10 as de-
1986; Bartsch et al., 1995, 1998). The motor neuron was impaledscribed (Bartsch et al., 1995) and used in the two-hybrid screening
with a glass microelectrode filled with 2.5 M KCl (10 MV resistance),as described previously (Fields and Song, 1989; Ausubel et al., 1993;
and its membrane potential was held at 30 mV below its restingDurfee et al., 1993). The transcriptional activation properties of ApAF
value. The EPSP was evoked by extracellular stimulation of theand its interaction with other proteins in the two-hybrid system
sensory neuron. Data were stored on a four channel tape recorder.were analyzed using the full-length ApAF and its deletion mutants
subcloned in pAS1 and pACT2 vectors. The transcriptional activity
of ApAF/GAL4 DNA binding domain fusions was determined as Induction of Facilitation by 5-HT and Antisera
and Recombinant Protein Injectiondescribed (Ma and Ptashne, 1987; Ausubel et al., 1993; Durfee et
al., 1993). To analyze the protein interactions, ApAF, ApCREB2, Two protocols were used to induce synaptic facilitation in Aplysia
cocultures. In the first, after testing the initial EPSP amplitude, 10 mMApC/EBP, and ApAF deletion mutants of these proteins in pAS1
and pACT2 were cotransformed into S. cerevisiae Y190, and the 5-HT was applied for 5 min (single pulse). The EPSP was retested
10 min (short-term facilitation) or 24 hr (long-term facilitation) afterexpressed b-galactosidase was quantified in nine independent colo-
nies as above. The b-galactosidase activity was standardized to washout of the 5-HT. The amount of facilitation was calculated as
the percentage change in EPSP amplitude recorded before and atboth the same protein content of the samples and the activity of
yeast expressing the Gal4 DNA binding domain-ApAF (279–398) the different time points after the single 5-HT application. In the
other group of experiments, long-term facilitation was evoked byfusion protein alone arbitrarily set as 1.
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five exposures to 10 mM 5-HT for 5 min each, at 20 min intervals (five tion into long-term functional and structural change. Cell 83,
979–992.pulses). The facilitation was calculated as the percentage change in
EPSP amplitude 24 hr after the five pulses of 5-HT. The antisera, Bartsch, D., Casadio, A., Karl, K.A., Serodio, P., and Kandel, E.R.
adjusted to the osmolarity of Aplysia neurons (Alberini et al., 1994), (1998). CREB1 encodes a nuclear activator, a repressor, and a cyto-
were pressure injected into the sensory neurons 1 hr before 5-HT plasmic modulator that form a regulatory unit critical for long-term
treatment. All recombinant proteins injected into sensory neurons facilitation. Cell 95, 211–223.
were expressed in E. coli as N-terminal 6xHistidine tagged fusion
Bourtchuladze, R., Frenguelli, B., Blendy, J., Cioffi, D., Schutz, G.,
proteins. For coinjection of pCREB1a protein with ApAF antisera,
and Silva, A.J. (1994). Deficient long-term memory in mice with a
10 ml of pCREB1a solution (1 mg/ml) was mixed with 1 ml of ApAF
targeted mutation of the cAMP- responsive element-binding protein.
antisera or preimmune sera. For coinjection of pCREB1a and ApAF
Cell 79, 59–68.
(279–398), the proteins were mixed in a 1:1 molar ratio, thus resulting
Brunelli, M., Castellucci, V., and Kandel, E.R. (1976). Synaptic facili-in dilution of pCREB1a to 0.5 mg/ml in the injection mix. All data
tation and behavioral sensitization in Aplysia: possible role of seroto-are presented as mean percentage change 6 SEM in the EPSP
nin and cyclic AMP. Science 194, 1178–1181.amplitude measured after treatment, as compared with its initial
Carew, T.J., and Kandel, E.R. (1973). Acquisition and retention ofpretreatment amplitude. A one-way analysis of variance and New-
long-term habituation in Aplysia: correlation of behavioral and cellu-man Keuls multiple range test were used to determine the signifi-
lar processes. Science 182, 1158–1160.cance of the EPSP changes.
Carew, T.J., Castellucci, V.F., and Kandel, E.R. (1971). An analysis
of dishabituation and sensitization of the gill-withdrawal reflex inLong-Term Exposure to 5-HT In Vitro and In Vivo
Aplysia. Int. J. Neurosci. 2, 79–98.In Aplysia cell cultures, we use five exposures to 10 mM 5-HT for
5 min each, at 20 min intervals (five pulses). We refer to this exposure Cowell, I.G., Skinner, A., and Hurst, H.C. (1992). Transcriptional re-
as repeated (spaced). To minimize handling of animals for in vivo pression by a novel member of the bZIP family of transcription
5-HT exposure, we incubate live animals in seawater with 50 mM factors. Mol. Cell. Biol. 12, 3070–3077.
5-HT for the time indicated. We refer to this exposure as extended Dash, P.K., Hochner, B., and Kandel, E.R. (1990). Injection of the
(massed). Massed 1 hr continuous exposure to 10 mM 5-HT induces cAMP-responsive element into the nucleus of Aplysia sensory neu-
long-term facilitation in cell culture, albeit less efficiently than the rons blocks long-term facilitation. Nature 345, 718–721.
spaced training.
Davis, H.P., and Squire, L.R. (1984). Protein synthesis and memory:
a review. Psychol. Bull. 96, 518–559.
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